about
Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient miceGABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice.Hyperhomocysteinemia is a result, rather than a cause, of depression under chronic stress.Folic acid mitigated cardiac dysfunction by normalizing the levels of tissue inhibitor of metalloproteinase and homocysteine-metabolizing enzymes postmyocardial infarction in miceVascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide researchThe quantitative significance of the transsulfuration enzymes for H2S production in murine tissues.Dietary methionine restriction in mice elicits an adaptive cardiovascular response to hyperhomocysteinemia.Increased cerebral blood volume pulsatility during head-down tilt with elevated carbon dioxide: the SPACECOT Study.Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.B-vitamins for neuroprotection: narrowing the evidence gap.Homocysteine as a Pathological Biomarker for Bone Disease.Correlations between homocysteine and grey matter volume in patients with Alzheimer's disease.TGFBR2 mutation and MTHFR-C677T polymorphism in a Mexican mestizo population with cervico-cerebral artery dissection.Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.Cardiovascular risk factors in polycystic ovary syndrome.Homocystinuria with lower gastrointestinal bleeding: first case report.Homocysteine in breast cyst fluid.Homocysteine thiolactone and protein homocysteinylation: mechanistic studies with model peptides and proteins.Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment.Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease.Intravenous treatment of hyperhomocysteinemia in patients on chronic hemodialysis--a pilot study.Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis and Accumulation of Advanced Glycation End Products by Reducing Oxidative Stress in MC3T3-E1 Cells.Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats.Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats.Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study.Plasma total homocysteine levels in subjects with hyperinsulinemia.Changes of plasma total homocysteine levels during the menstrual cycle.Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients.Association between homocysteine levels and calcific aortic valve disease: a systematic review and meta-analysis.
P2860
Q28504883-BC4DFD75-8AEA-4F97-976E-BD1D3891D973Q33609855-F7E9116B-7A4C-44D2-BE16-A51F4BD92F3CQ34294265-7A6DFFC2-3C34-484E-833F-840EEF3742D9Q34357653-333B5372-7FC3-4AA2-A3A0-34513C4AA13CQ34502082-F71321E7-3E02-4388-A55C-092D470949CBQ35056200-AD777436-9CB3-4E05-A9D4-DECDA57C0A7BQ35153245-058476B0-5093-4C66-A193-3D7A3F421FFFQ36329004-E7CDBCB9-FE72-4E21-A2EE-CF47D184F9E9Q37347147-2A9DECAF-F938-4B5D-AA0C-05B22C653626Q37993820-3EE5BD59-0724-4A50-B5DE-8729EDE72401Q39012193-87DF069E-9F0B-47C9-9BF6-14CE3699ECBBQ39064336-DD42DD78-0323-4287-BB7F-25CF57FF8564Q39887169-9ECD12AA-84A9-45CC-AE36-57137A538D56Q41208237-A55FEACD-53A2-4C5D-93D2-E506F2EE20B4Q42471238-7EB51B13-1B88-4D25-B0E3-6D654BB8C01CQ42759755-F8009A39-0C95-46AF-B675-086B084397C4Q43674615-579ED890-4D13-4040-829F-E8DEA9ECF5C0Q43981178-31E5AAAF-3619-4149-9ABA-02BF82DD1537Q44517339-D5DAF10E-0008-4B54-9342-BAB2EEB59478Q44585201-F7C6B406-389E-4791-846A-F34DE82D5A02Q44960744-E68A1175-2315-47A2-A3ED-7A07C262A6FDQ45188151-004CC527-D2FD-430A-8A86-A5FBD0CBBFB4Q46461427-30714DA0-75BE-41E3-8A48-FF72F13EAE18Q46663117-4CA8792C-B7AE-4992-8C96-DB94F6381863Q46738131-48B5DBEA-0BF6-4D24-A2C8-F27C6A4478E6Q47640555-9E34CE86-61E2-4EB9-82D8-3979F9BF517AQ51558073-AA68AEDB-B33C-403B-BA7C-7AF09E2EF6BFQ51559634-DD7E335D-4687-4BEA-9B84-8BE7F3FEA690Q51800181-32B5238E-A68E-41B3-83A2-4591B8FCB78FQ52680475-21E45D33-8F49-4C26-A1A9-FD6EC9336CC6
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Homocysteine and vascular dysfunction.
@en
type
label
Homocysteine and vascular dysfunction.
@en
prefLabel
Homocysteine and vascular dysfunction.
@en
P1433
P1476
Homocysteine and vascular dysfunction
@en
P2093
P304
P356
10.1016/S0024-3205(97)00392-5
P407
P577
1997-01-01T00:00:00Z